De-Escalated Axillary Treatment After Neoadjuvant Systemic Therapy According to the MARI Protocol in Clinically Node-Positive Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol
Breast Cancer Res Treat 2022 May 01;193(1)37-48, AA van Loevezijn, MEM van der Noordaa, MPM Stokkel, ED van Werkhoven, EJ Groen, CE Loo, PHM Elkhuizen, GS Sonke, NS Russell, FH van Duijnhoven, MTFD Vrancken PeetersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.